Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

250.80
Delayed Data
As of 3:59pm ET
 -2.17 / -0.86%
Today’s Change
205.42
Today|||52-Week Range
307.33
-3.98%
Year-to-Date
Merck (MRK) Buys Rights to Anti-tau Antibody for Alzheimer
10:18am / Zacks.com - Paid Partner Content
Woodford Investment Management LLP Buys Gilead Sciences Inc, Bioverativ Inc, Biogen I...
May 22 / GuruFocus News - Paid Partner Content
Charting the Biotechs
10:02am / TheStreet.com - Paid Partner Content
Celgene Stock Rises Premarket on Positive Late-Stage Test Results for Multiple Sclero...
May 22 / TheStreet.com - Paid Partner Content
Biogen (BIIB) Down 9.5% Since Earnings Report: Can It Rebound?
4:29am / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Biogen Inks Deal to Boost Pipeline, Sangamo Soars on Pfizer De...
May 17 / Zacks.com - Paid Partner Content
Biogen's Fampyra Conditional Approval Converted to Standard
May 25 / Zacks.com - Paid Partner Content
Biogen (BIIB) Buys Stroke Candidate Cirara for $120M
May 16 / Zacks.com - Paid Partner Content
Jeff Ubben Buys 1, Sells 1 in 1st Quarter
May 24 / GuruFocus News - Paid Partner Content